Prognostic Value of Residual Fluorescent Tissue in Glioblastoma Patients After Gross Total Resection in 5-Aminolevulinic Acid-Guided Surgery

Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery

(2012) Walter Stummer et al.   JOURNAL OF NEURO-ONCOLOGY

Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients

(2012) Maurizio Salvati et al.   JOURNAL OF NEUROSURGERY

Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography (18F-FET PET) in glioblastoma surgery

(2012) Karl Roessler et al.   NEUROLOGICAL RESEARCH

Gross Total Resection Rates in Contemporary Glioblastoma Surgery

(2012) Philippe Schucht et al.   NEUROSURGERY

An extent of resection threshold for newly diagnosed glioblastomas

(2011) Nader Sanai et al.   JOURNAL OF NEUROSURGERY

Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance

(2011) D. Kuhnt et al.   NEURO-ONCOLOGY

Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence

(2011) Miguel Angel Idoate et al.   NEUROPATHOLOGY

Quantification of Glioma Removal by Intraoperative High-Field Magnetic Resonance Imaging: An Update

(2011) Daniela Kuhnt et al.   NEUROSURGERY

Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas

(2011) Michael A. Vogelbaum et al.   NEUROSURGERY

Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy

(2010) Robert M. Prins et al.   CLINICAL CANCER RESEARCH

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

(2010) Hilko Ardon et al.   JOURNAL OF NEURO-ONCOLOGY

Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience

(2010) Ricardo Díez Valle et al.   JOURNAL OF NEURO-ONCOLOGY

Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study

(2010) Walter Stummer et al.   JOURNAL OF NEUROSURGERY

Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid–induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters

(2010) David W. Roberts et al.   JOURNAL OF NEUROSURGERY

A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme

(2009) Kaisorn Chaichana et al.   JOURNAL OF NEUROSURGERY

Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring

(2009) Guenther C. Feigl et al.   JOURNAL OF NEUROSURGERY

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

POSITRON EMISSION TOMOGRAPHY-GUIDED VOLUMETRIC RESECTION OF SUPRATENTORIAL HIGH-GRADE GLIOMAS

(2009) Benoit J.M. Pirotte et al.   NEUROSURGERY

IMPACT OF INTRAOPERATIVE HIGH‐FIELD MAGNETIC RESONANCE IMAGING GUIDANCE ON GLIOMA SURGERY

(2009) Mustafa Aziz Hatiboglu et al.   NEUROSURGERY

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

(2008) Matthew J. McGirt et al.   JOURNAL OF NEUROSURGERY